BRPI0821255A2 - Derivados de espiroindolinona - Google Patents

Derivados de espiroindolinona

Info

Publication number
BRPI0821255A2
BRPI0821255A2 BRPI0821255-4A BRPI0821255A BRPI0821255A2 BR PI0821255 A2 BRPI0821255 A2 BR PI0821255A2 BR PI0821255 A BRPI0821255 A BR PI0821255A BR PI0821255 A2 BRPI0821255 A2 BR PI0821255A2
Authority
BR
Brazil
Prior art keywords
spiroindolinone derivatives
spiroindolinone
derivatives
compounds
esters
Prior art date
Application number
BRPI0821255-4A
Other languages
English (en)
Inventor
Qingjie Ding
Nan Jiang
Song Yang
Jing Zhang
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0821255A2 publication Critical patent/BRPI0821255A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0821255-4A 2007-12-14 2008-12-05 Derivados de espiroindolinona BRPI0821255A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1369107P 2007-12-14 2007-12-14
US10743108P 2008-10-22 2008-10-22
PCT/EP2008/066874 WO2009077357A1 (en) 2007-12-14 2008-12-05 Spiroindolinone derivatives

Publications (1)

Publication Number Publication Date
BRPI0821255A2 true BRPI0821255A2 (pt) 2015-06-16

Family

ID=40289301

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821255-4A BRPI0821255A2 (pt) 2007-12-14 2008-12-05 Derivados de espiroindolinona

Country Status (12)

Country Link
US (1) US8134001B2 (pt)
EP (1) EP2229396B1 (pt)
JP (1) JP2011506380A (pt)
KR (1) KR20100076037A (pt)
CN (1) CN101896486A (pt)
AT (1) ATE519764T1 (pt)
AU (1) AU2008337651A1 (pt)
BR (1) BRPI0821255A2 (pt)
CA (1) CA2707456A1 (pt)
IL (1) IL205354A0 (pt)
MX (1) MX2010006107A (pt)
WO (1) WO2009077357A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776875B2 (en) * 2007-12-19 2010-08-17 Hoffman-La Roche Inc. Spiroindolinone derivatives
US8354444B2 (en) * 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
KR20120099462A (ko) 2009-11-12 2012-09-10 더 리젠츠 오브 더 유니버시티 오브 미시건 스피로-옥신돌 ｍｄｍ2 길항제
US8288431B2 (en) * 2010-02-17 2012-10-16 Hoffmann-La Roche Inc. Substituted spiroindolinones
AU2011326395B2 (en) 2010-11-12 2016-01-07 Ascenta Licensing Corporation Spiro-oxindole MDM2 antagonists
CN102584835B (zh) * 2011-01-17 2014-08-27 苏州大学 一种含吲哚结构的螺杂环化合物及其制备方法
AU2012226890B2 (en) 2011-03-10 2016-10-06 Daiichi Sankyo Company, Limited Dispiropyrrolidine derivative
US8629141B2 (en) 2011-05-11 2014-01-14 The Regents Of The University Of Michigan Spiro-oxindole MDM2 antagonists
CN102321095B (zh) * 2011-05-26 2014-09-10 兰州大学 手性螺环吲哚-吡喃嘧啶碱类化合物及其制备和应用
MX352672B (es) * 2011-09-27 2017-12-04 Amgen Inc Compuestos heterocíclicos como inhibidores de mdm2 para el tratamiento del cáncer.
CN102627650B (zh) * 2012-03-08 2015-07-08 徐州师范大学 手性四氢吡咯-3,2′-氧化吲哚螺环化合物及其合成方法
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
WO2015027067A2 (en) * 2013-08-23 2015-02-26 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
JP6503386B2 (ja) 2014-07-03 2019-04-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ＭＤＭ２−ｐ５３阻害剤としての新しいスピロ［３Ｈ−インドール−３，２’−ピロリジン］−２（１Ｈ）−オン化合物および誘導体
CA2956129C (en) 2014-08-21 2022-10-25 Boehringer Ingelheim International Gmbh New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
JP6564449B2 (ja) 2015-02-20 2019-08-21 第一三共株式会社 がんの併用治療法
HK1251165A1 (en) 2015-04-13 2019-01-25 Daiichi Sankyo Company, Limited Treatment method combining mdm2 inhibitor and btk inhibitor
PL3359542T3 (pl) 2015-10-09 2021-09-20 Boehringer Ingelheim International Gmbh Związki i pochodne spiro[3h-indolo-3,2’-pirolidyno]-2(1h)-onowe jako inhibitory mdm2-p53
EP3458101B1 (en) 2016-05-20 2020-12-30 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
US20190240210A1 (en) 2016-10-17 2019-08-08 Daiichi Sankyo Company, Limited Treatment Method by Combined Use of MDM2 Inhibitor and DNA Methyltransferase Inhibitor
WO2020179859A1 (ja) 2019-03-06 2020-09-10 第一三共株式会社 ピロロピラゾール誘導体
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
CN116253736B (zh) * 2023-01-06 2024-06-18 中山大学 一种吡唑β-内酰胺类衍生物及其制备方法和应用
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070213341A1 (en) * 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
US7495007B2 (en) 2006-03-13 2009-02-24 Hoffmann-La Roche Inc. Spiroindolinone derivatives
CA2644758A1 (en) 2006-03-13 2007-09-20 F. Hoffmann-La Roche Ag Spiroindolinone derivatives
US7638548B2 (en) 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives

Also Published As

Publication number Publication date
JP2011506380A (ja) 2011-03-03
CN101896486A (zh) 2010-11-24
EP2229396B1 (en) 2011-08-10
AU2008337651A1 (en) 2009-06-25
US20090156610A1 (en) 2009-06-18
US8134001B2 (en) 2012-03-13
MX2010006107A (es) 2010-06-25
EP2229396A1 (en) 2010-09-22
KR20100076037A (ko) 2010-07-05
WO2009077357A1 (en) 2009-06-25
CA2707456A1 (en) 2009-06-25
IL205354A0 (en) 2010-12-30
ATE519764T1 (de) 2011-08-15

Similar Documents

Publication Publication Date Title
BRPI0821255A2 (pt) Derivados de espiroindolinona
BRPI0820699A2 (pt) derivados de espieoindolina
ATE495176T1 (de) Spiroindolinon-derivate
MY160424A (en) Substituted pyrrolidine-2-carboxyamides.
CR20110684A (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
MX2012009186A (es) Pirrolidina-2-carboxamidas sustituidas.
TW200801000A (en) Spiroindolinone derivatives
IN2012DN02487A (pt)
MX2011008176A (es) Derivados de 3,3'-espiroindolinona como agentes anticancerigenos.
WO2007084728A3 (en) 2-imino-benzimidazoles
WO2007117465A3 (en) Indazole compounds
BRPI0717266A2 (pt) Derivados de oxindol
BRPI0716598A2 (pt) Derivados de (hetero) arilsulfonamida de n-biarila úteis no tratamento de doenças medidas por interações de linfócitos
TW200740758A (en) Benzoquinazoline derivatives
MX2009003081A (es) Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
EP2581372A4 (en) CYANOCHINOLINDERIVATE
MX2011007886A (es) Derivado de espiroindolinona piridina.
ATE528290T1 (de) Spiroindolinon-derivate
TNSN08369A1 (en) Benzimidazole derivatives
ATE469647T1 (de) Thienoä3,2-cüpyridin-7-carbonsäure-derivate
EA200970692A1 (ru) Способы улучшения стабильности стероидных производных
EA200901085A1 (ru) Производные циклогексиламида арилкарбоновой кислоты
MX2010008778A (es) Derivados de 3-alquil-piperazina y usos de la misma.
UA103497C2 (en) Substituted pyrrolidine-2-carboxamides

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.